BRIEF published on 05/20/2024 at 13:14, 1 year 9 months ago Edison Issues Update on Target Healthcare REIT: Q3 Shows Continued Positive Momentum REIT Dividends Property Values Target Healthcare REIT Q3 Update
BRIEF published on 05/20/2024 at 13:14, 1 year 9 months ago Edison publie une mise à jour sur Target Healthcare REIT : le troisième trimestre montre une dynamique positive continue Dividendes FPI FPI De Soins De Santé Cible Mise À Jour Du Troisième Trimestre Valeurs Des Propriétés
BRIEF published on 05/20/2024 at 13:05, 1 year 9 months ago Lahontan Gold Corp Mobilizes Drill Rig to Santa Fe Mine Project Mineral Resource Estimate Preliminary Economic Assessment Lahontan Gold Corp Santa Fe Mine Drill Rig
BRIEF published on 05/20/2024 at 13:05, 1 year 9 months ago Lahontan Gold Corp mobilise une plate-forme de forage pour le projet minier de Santa Fe Estimation Des Ressources Minérales Evaluation Économique Préliminaire Lahontan Gold Corp. Mine De Santa Fé Appareil De Forage
BRIEF published on 05/20/2024 at 13:05, 1 year 9 months ago Aclara Appoints Dr. Kurt Forrester as Lead Advisor to Its Heavy Rare Earths Separation Project Rare Earths Sustainable Energy Aclara Resources Vertical Integration Dr. Kurt Forrester
BRIEF published on 05/20/2024 at 13:05, 1 year 9 months ago Aclara nomme le Dr Kurt Forrester au poste de conseiller principal pour son projet de séparation des terres rares lourdes Terres Rares Ressources D'Aclara L'énergie Durable Intégration Verticale Dr Kurt Forrester
BRIEF published on 05/20/2024 at 12:58, 1 year 9 months ago Edison Issues Review on BB Biotech (BION): A Recovering Sector with a Healthy Prognosis Investment Dividend Biotech Sector Market Outlook BB Biotech
BRIEF published on 05/20/2024 at 12:58, 1 year 9 months ago Edison publie une revue sur BB Biotech (BION) : un secteur en reprise avec un pronostic sain Investissement Dividende Perspectives Du Marché BB Biotechnologie Secteur Biotechnologique
BRIEF published on 05/20/2024 at 12:35, 1 year 9 months ago NV-387 Shows Promising Results in Treating Lethal RSV Infection in Animal Study NanoViricides NV-387 Clinical Trials Antiviral RSV
BRIEF published on 05/20/2024 at 12:35, 1 year 9 months ago Le NV-387 montre des résultats prometteurs dans le traitement de l'infection mortelle par le VRS dans une étude animale NanoViricides NV-387 Essais Cliniques Antiviral VRS
Published on 03/07/2026 at 00:00, 9 hours 40 minutes ago Green Bridge Metals to Ship Titac Drill Core for Metallurgical Testing to Evaluate Titanium Dioxide Extraction Potential
Published on 03/06/2026 at 22:30, 11 hours 10 minutes ago Sceptre Ventures Announces Amendment and Closing of Private Placement Offering
Published on 03/06/2026 at 22:00, 11 hours 40 minutes ago Pegasus Resources Inc. Announces Annual General and Special Meeting of Shareholders
Published on 03/06/2026 at 17:55, 15 hours 45 minutes ago High Tide Resources Announces Upsize to Private Placement
Published on 03/06/2026 at 14:00, 19 hours 40 minutes ago CHAR Technologies Announces Increase to C$ 3.97M and Closing of Book on Previously Announced Private Placement
Published on 03/07/2026 at 02:03, 7 hours 37 minutes ago EQS-Adhoc: Heidelberg Pharma and HealthCare Royalty Announce Amendment to Existing Royalty Agreement and the Participation of Soleus Capital
Published on 03/06/2026 at 23:05, 10 hours 34 minutes ago DeFi Technologies Receives Nasdaq Notification Letter Regarding Minimum Bid Price Deficiency
Published on 03/06/2026 at 19:30, 14 hours 9 minutes ago TRADE SHOWS: IEG, OUTSTANDING RESULTS FOR KEY - THE ENERGY TRANSITION EXPO WITH +10% TOTAL VISITORS AND +9% FROM ABROAD
Published on 03/06/2026 at 18:44, 14 hours 55 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 03/06/2026 at 18:30, 15 hours 9 minutes ago WHO Foundation announces collaboration with Lilly to strengthen health systems for obesity care
Published on 03/06/2026 at 18:05, 15 hours 35 minutes ago AXA: Information relating to the number of voting rights and shares making up the share capital on 28/02/2026
Published on 03/06/2026 at 18:05, 15 hours 35 minutes ago AXA : Information relative au nombre total de droits de vote et d'actions composant le capital social au 28/02/2026
Published on 03/06/2026 at 18:00, 15 hours 40 minutes ago Outstanding shares and voting rights statement at 28 February 2026
Published on 03/06/2026 at 18:00, 15 hours 40 minutes ago Publication du nombre d’actions composant le capital et du nombre total de droits de vote au 28 février 2026
Published on 03/06/2026 at 18:00, 15 hours 40 minutes ago Informations relatives au nombre total de droits de vote et d’actions composant le capital social au 27 février 2026
